Transforming patient recovery

with bioresorbable medical devices

icon_partnering

About Polyganics

An innovative medical technology company developing and delivering unique medical devices to improve surgical outcomes and patient recovery

icon_technology

Technology Platform

Using state-of-the-art technology platforms to produce versatile bioresorbable and biocompatible synthetic polymers

Product Portfolio

Developing medical devices for use in targeted clinical applications to drive natural tissue repair and regeneration

We are currently not recruiting. An unsolicited application (CV and cover letter) can be sent to hrm@polyganics.com

Polyganics Achieves CE Mark Certification for LIQOSEAL® 7 January 2020
Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL® 17 September 2019
Polyganics Builds New Facility to Continue Growth, Supported by RIG Subsidy of €3.8 Million 10 April 2019

European Association of Neurosurgical Societies (EANS) – 19th European Congress of Neurosurgery

September 24- September 28, 2019

Dublin, Ireland

Visit booth #56

Oral presentations – Friday September 27, 2019 – 10:00-10:40- Poster booth 1 (E poster area):
- Development of a new dural sealing device from the bench to the neurosurgical bed – T. van Doormaal
- Optimization of watertight spinal dural sealing – A. Kinaci